---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020007"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:14:43.901112+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics files PCT patent for ImmunePrep platform to enhance antibody delivery for cancer treatment

## Summary
- Filed PCT application US24/28579 on May 9, 2024 for 'DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES'.
- Patent covers ImmunePrep platform aimed at improving delivery of immunotherapeutic antibodies for cancer.
- Inventors listed: Chairman and CEO James A. Joyce and Annette M. Marleau.

## SEC filing metadata
- accession: 0001493152-24-020007
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/0001493152-24-020007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224020007/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020007
- JSON: https://secwatch.observer/filing/0001493152-24-020007.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.